Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma

• Hoofdauteurs: Roberto Ria (Auteur), Antonia Reale (Auteur), Antonio Giovanni Solimando (Auteur), Giuseppe Mangialardi (Auteur), Michele Moschetta (Auteur), Lucia Gelao (Auteur), Giuseppe Iodice (Auteur), Angelo Vacca (Auteur)
• Formaat: Boek
• Gepubliceerd in: Hindawi Limited, 2012-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Autologous stem cell transplantation (ASCT) is considered the standard therapy for younger patients with newly diagnosed symptomatic multiple myeloma (MM). The introduction into clinical practice of novel agents, such as the proteasome inhibitor bortezomib and the immunomodulatory derivatives (IMiDs...